News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
639,061 Results
Type
Article (43916)
Company Profile (173)
Press Release (594956)
Multimedia
Podcasts (111)
Webinars (25)
Section
Business (170549)
Career Advice (2501)
Deals (30796)
Drug Delivery (133)
Drug Development (75626)
Employer Resources (151)
FDA (15368)
Job Trends (13657)
News (298339)
Policy (29065)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2774)
Academic (1)
Accelerated approval (54)
ADA (49)
Adcomms (35)
Allergies (197)
Alliances (44241)
ALS (224)
Alzheimer's disease (1874)
Antibody-drug conjugate (ADC) (523)
Approvals (15782)
Artificial intelligence (745)
ASCO (345)
Autoimmune disease (332)
Automation (60)
Bankruptcy (319)
Best Places to Work (11108)
BIOSECURE Act (17)
Biosimilars (220)
Biotechnology (108)
Bladder cancer (205)
Brain cancer (79)
Breast cancer (783)
Cancer (6229)
Cardiovascular disease (514)
Career advice (2130)
Career pathing (46)
CAR-T (353)
CDC (57)
Celiac Disease (1)
Cell therapy (961)
Cervical cancer (47)
Clinical research (66588)
Collaboration (2221)
Commercialization (1)
Company closure (6)
Compensation (943)
Complete response letters (89)
COVID-19 (2701)
CRISPR (112)
C-suite (1263)
Cystic fibrosis (139)
Data (8449)
Decentralized trials (3)
Denatured (35)
Depression (185)
Dermatology (95)
Diabetes (651)
Diagnostics (6914)
Digital health (59)
Diversity (9)
Diversity, equity & inclusion (41)
Drug discovery (354)
Drug pricing (203)
Drug shortages (29)
Duchenne muscular dystrophy (303)
Earnings (67209)
Editorial (66)
Employer branding (19)
Employer resources (141)
Events (96357)
Executive appointments (1174)
FDA (19226)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (33)
Funding (1814)
Gene editing (243)
Generative AI (62)
Gene therapy (774)
GLP-1 (1114)
Government (4683)
Grass and pollen (7)
Guidances (416)
Healthcare (18191)
Hematology (182)
HIV (90)
Huntington's disease (60)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (110)
Immunology and inflammation (317)
Immuno-oncology (109)
Indications (204)
Infectious disease (3067)
Inflammatory bowel disease (220)
Inflation Reduction Act (14)
Influenza (139)
Intellectual property (310)
Interviews (534)
IPO (14097)
IRA (54)
Job creations (2883)
Job search strategy (1708)
JPM (64)
Kidney cancer (22)
Labor market (81)
Layoffs (556)
Leadership (49)
Legal (6260)
Liver cancer (105)
Longevity (31)
Lung cancer (846)
Lymphoma (461)
Machine learning (57)
Management (53)
Manufacturing (1094)
Marketing (1)
MASH (225)
Medical affairs (1)
Medical device (13483)
Medtech (13632)
Mergers & acquisitions (17970)
Metabolic disorders (1645)
mRNA (225)
Multiple sclerosis (196)
NASH (24)
Neurodegenerative disease (470)
Neuropsychiatric disorders (120)
Neuroscience (3509)
Neurotech (1)
NextGen: Class of 2026 (6161)
Non-profit (4492)
Now hiring (71)
Obesity (744)
Opinion (319)
Ovarian cancer (236)
Pain (270)
Pancreatic cancer (343)
Parkinson's disease (390)
Partnered (34)
Patents (616)
Patient recruitment (746)
Peanut (64)
People (57122)
Pharmaceutical (46)
Pharmacy benefit managers (24)
Phase 1 (20578)
Phase 2 (29313)
Phase 3 (22199)
Pipeline (9535)
Policy (340)
Postmarket research (2361)
Preclinical (8446)
Press Release (68)
Prostate cancer (332)
Psychedelics (65)
Radiopharmaceuticals (344)
Rare diseases (1161)
Real estate (4967)
Recruiting (66)
Regulatory (23764)
Reports (35)
Research institute (2460)
Resumes & cover letters (366)
Rett syndrome (40)
RNA editing (25)
RSV (84)
Schizophrenia (187)
Series A (309)
Series B (220)
Service/supplier (8)
Sickle cell disease (124)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (48)
Startups (3242)
State (2)
Stomach cancer (19)
Supply chain (129)
Tariffs (84)
The Weekly (73)
Vaccines (1098)
Venture capital (120)
Weight loss (492)
Women's health (121)
Worklife (20)
Date
Today (107)
Last 7 days (515)
Last 30 days (2751)
Last 365 days (29367)
2026 (14727)
2025 (29196)
2024 (33631)
2023 (37797)
2022 (48341)
2021 (52277)
2020 (50828)
2019 (44620)
2018 (33796)
2017 (30175)
2016 (28954)
2015 (33672)
2014 (25444)
2013 (20696)
2012 (22231)
2011 (23032)
2010 (20401)
Location
Africa (801)
Alabama (91)
Alaska (7)
Arizona (292)
Arkansas (15)
Asia (39074)
Australia (7602)
California (12519)
Canada (3736)
China (1516)
Colorado (550)
Connecticut (554)
Delaware (429)
Europe (89465)
Florida (1983)
Georgia (423)
Hawaii (3)
Idaho (57)
Illinois (1111)
India (95)
Indiana (616)
Iowa (23)
Japan (579)
Kansas (123)
Kentucky (45)
Louisiana (58)
Maine (74)
Maryland (1544)
Massachusetts (8965)
Michigan (377)
Minnesota (707)
Mississippi (6)
Missouri (148)
Montana (31)
Nebraska (28)
Nevada (147)
New Hampshire (88)
New Jersey (3564)
New Mexico (30)
New York (3474)
North Carolina (1621)
North Dakota (11)
Northern California (6184)
Ohio (403)
Oklahoma (23)
Oregon (40)
Pennsylvania (2556)
Puerto Rico (29)
Rhode Island (48)
South America (1081)
South Carolina (87)
South Dakota (2)
Southern California (5073)
Tennessee (211)
Texas (2100)
United States (45414)
Utah (401)
Vermont (1)
Virginia (320)
Washington D.C. (78)
Washington State (1061)
West Virginia (4)
Wisconsin (149)
Wyoming (2)
639,061 Results for "dariohealth formerly known as labstyle innovations".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mighty Therapeutics, Formerly Stealth BioTherapeutics, Announces New Name Honoring the Mitochondrial Disease Community
June 16, 2026
·
6 min read
China
Pfizer bets up to $10.5B in 12-candidate cancer collab with China’s Innovent
Pfizer continues its dealmaking spree by striking a back-heavy partnership with China’s Innovent Biologics to assemble a pipeline of antibody-based therapies for cancer.
May 29, 2026
·
2 min read
·
Tristan Manalac
Press Releases
REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
March 30, 2026
·
19 min read
Press Releases
The American Diabetes Association Announces Winners of the Innovation Challenge
June 8, 2026
·
3 min read
Manufacturing
Innovent’s CDMO gets green light to make biologics at large Chinese plant
The license, which Innovent’s Altruist business said is the first of its kind, positions the CDMO to support commercial clients as it works to expand the plant’s capacity to 172,000 liters.
April 9, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Thermo Fisher Scientific Expands Orbitrap Innovation Across Research, Biopharma and Applied Testing at ASMS 2026
June 2, 2026
·
8 min read
Cancer
ASCO’s biggest winners showcased a new era of cancer innovation
Revolution Medicines stole the show at the 2026 American Society of Clinical Oncology meeting as full data from its pancreatic cancer drug lived up to expectations, while Summit and Akeso proved the PD-(L)1/VEGF mechanism and Eli Lilly showed that its in vivo CAR T bet is paying off.
June 3, 2026
·
7 min read
·
Heather McKenzie
Press Releases
Recludix Pharma Announces Preclinical Data Demonstrating Efficacy Comparable to Monoclonal Antibodies Targeting IL-4/IL-13 Signaling Pathways and Differentiated Safety Profile of Oral STAT6 Inhibitor REX-8756 (also known as SAR448755) in a Model of Atopic Dermatitis
May 17, 2026
·
3 min read
Press Releases
Foundation Medicine Showcases Innovation at 2026 ASCO® Annual Meeting
May 22, 2026
·
6 min read
Opinion
Biotech can’t continue to innovate under strain of Big Pharma market pressures
Biotech is increasingly financed, governed and regulated as though it were a mature pharmaceutical industry rather than a discovery system built around scientific uncertainty. Structural changes are needed to sustain the sector’s strategic innovation.
May 19, 2026
·
5 min read
·
Jeremy Levin
1 of 63,907
Next
